AMBRISENTAN for Obesity: Side Effects & Safety Data
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
There are 60 adverse event reports in the FDA FAERS database where AMBRISENTAN was used for Obesity.
Most Reported Side Effects for AMBRISENTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 13,367 | 15.5% | 652 | 6,217 |
| Death | 7,497 | 8.7% | 7,442 | 1,241 |
| Headache | 7,325 | 8.5% | 203 | 1,884 |
| Pneumonia | 4,693 | 5.4% | 368 | 3,802 |
| Dizziness | 4,561 | 5.3% | 93 | 1,261 |
| Fatigue | 4,436 | 5.2% | 145 | 1,312 |
| Diarrhoea | 4,312 | 5.0% | 168 | 1,512 |
| Nausea | 3,986 | 4.6% | 153 | 1,297 |
| Fluid retention | 3,927 | 4.6% | 212 | 2,212 |
| Malaise | 3,839 | 4.5% | 214 | 1,491 |
| Peripheral swelling | 3,461 | 4.0% | 128 | 1,107 |
| Cough | 3,067 | 3.6% | 85 | 899 |
| Nasal congestion | 3,019 | 3.5% | 36 | 423 |
| Oedema peripheral | 2,959 | 3.4% | 114 | 882 |
| Oedema | 2,651 | 3.1% | 109 | 923 |
Other Indications for AMBRISENTAN
Product used for unknown indication (35,884)
Pulmonary arterial hypertension (27,852)
Pulmonary hypertension (18,885)
Scleroderma (1,547)
Cor pulmonale chronic (879)
Connective tissue disorder (857)
Heart disease congenital (772)
Chronic obstructive pulmonary disease (460)
Portopulmonary hypertension (428)
Sleep apnoea syndrome (352)
Other Drugs Used for Obesity
SEMAGLUTIDE (2,586)
LIRAGLUTIDE (1,090)
BUPROPION\NALTREXONE (726)
TIRZEPATIDE (700)
ORLISTAT (163)
PHENTERMINE (127)
DULAGLUTIDE (109)
METFORMIN (100)
PHENTERMINE\TOPIRAMATE (86)
TOPIRAMATE (86)